CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Practice Management

Pages: 1  2  3  
Previous Next
 

Apollo finds mobile MRI a good risk through SMT and Alliance acquisitions

August 6, 1997

While Apollo has invested in healthcare since its inception in 1990, this is the firm's first foray into imaging services. The business may provide a platform for Apollo to expand both within imaging and outside, providing other types of services to hospitals, Harris told SCAN.

"Allowing hospitals to outsource services that are not fundamentally core to them can be a growing and good business, as long as you do it on a cost-efficient basis," he said. "We see (annual growth in) demand of between 5% and 10%, which is greater than in other areas. There are also opportunities within the industry to consolidate and take cost out of the business."

The Apollo investment is significantly less leveraged than Alliance's management-led buyout in 1988, Zehner said (SCAN 11/9/88). The new owners will sink $80 million of equity into Alliance.

Alliance expects that Apollo's assistance and funding will fortify its effort to build market share in MRI shared services, he said.

"We will be able to grow more," Zehner said. "These people (Apollo) have about $9 billion under management. If we need to do other acquisitions or grow the core business or even enter new lines of business, they will be able to either raise the funds or provide the funds for us to grow at a more rapid rate."

Brighter prospects. Rising procedural volume in MRI has helped compensate for radically lower reimbursement rates per procedure, Zehner said. Both Alliance and SMT displayed a sharp rise in revenue and net income in their 1997 second quarters (both end-June).

Alliance's second-quarter revenues this year rose 25% to $20.8 million, and net earnings jumped 39% to $2.4 million. SMT's quarterly revenue jumped 50% to $7 million, and net income increased 56% to $879,000. Reflecting greater scan volume in the industry, SMT experienced a 21% increase in quarterly revenues from hospitals the company serviced in both 1996 and 1997.

Pages: 1  2  3  
Previous Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • Skin Lesions
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Practice Management
Evidence on Practice Management
Guidelines on Practice Management
Patient Education on Practice Management
Clinical Trials on Practice Management
Practical Articles on Practice Management
Research and Reviews on Practice Management
All "Practice Management" results

CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy